Basant Elsayed
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Basant Elsayed has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Ahmed Amarah
Basic Medical Sciences Department, College of Medicine, QU Health, Qatar University, Doha 2713, Qatar
1 shared publication - Ahmed Daniyal Nawaz
Medicine , Hamad Medical Corporation , Doha , Qatar , hamad.qa
1 shared publication - Amine Zaidi
Basic Medical Sciences Department, College of Medicine, QU Health, Qatar University, Doha 2713, Qatar
1 shared publication - Devendra Bansal
Health Protection and Communicable Disease Control, Ministry of Public Health, Doha, Qatar
1 shared publication - Elmoubasher Farag
Department of Health Protection and Communicable Diseases, Ministry of Public Health, Doha, Qatar
1 shared publication - Fardous Abbasher
Basic Medical Sciences Department, College of Medicine, QU Health, Qatar University, Doha 2713, Qatar
1 shared publication
Latest Publications
- Open Access
- 8 February 2024
- Published by IntechOpen
Perspective Chapter: Epidemiology and Risk Factors of Diabetic Foot Ulcer
Diabetes is one of the most common diseases worldwide, with steady increase in its prevalence around the globe. One of the common and most devastating complication of such disease is diabetic foot ulcer. The prevalence of diabetic foot ulcers (DFU) among adults with diabetes globally has been estimated at 6.3%, while the annual incidence has been reported to range between 9.1 to 26.1 million cases. DFU is associated with several risk factors including a longer duration of diabetes, poorly controlled diabetes, diabetic neuropathy and foot deformities such as foot callus and flat foot. It can also result in many complications, among which infections are the leading cause of morbidity and mortality. Infections are estimated to occur in 60% of all diabetic ulcers. Moreover, the mortality rate is higher by 2.5-fold in patients with diabetes with foot ulcers compared to patients with diabetes without foot ulcers. In this chapter, we discuss the epidemiology of DFU, and review its prevalence in different parts of the world, along with risk factors, complication rates and overall impact on quality of life.
- 8 February 2024
- Published by IntechOpen
Open AccessPerspective Chapter: Epidemiology and Risk Factors of Diabetic Foot Ulcer
Diabetes is one of the most common diseases worldwide, with steady increase in its prevalence around the globe. One of the common and most devastating complication of such disease is diabetic foot ulcer. The prevalence of diabetic foot ulcers (DFU) among adults with diabetes globally has been estimated at 6.3%, while the annual incidence has been reported to range between 9.1 to 26.1 million cases. DFU is associated with several risk factors including a longer duration of diabetes, poorly controlled diabetes, diabetic neuropathy and foot deformities such as foot callus and flat foot. It can also result in many complications, among which infections are the leading cause of morbidity and mortality. Infections are estimated to occur in 60% of all diabetic ulcers. Moreover, the mortality rate is higher by 2.5-fold in patients with diabetes with foot ulcers compared to patients with diabetes without foot ulcers. In this chapter, we discuss the epidemiology of DFU, and review its prevalence in different parts of the world, along with risk factors, complication rates and overall impact on quality of life.
- Open Access
- 20 February 2023
- Published by MDPI AG in Microbiology Research
- Vol. 14 (1) , 289-296
Association between Multimorbidity and COVID-19 Mortality in Qatar: A Cross-Sectional Study
This study assessed the association between multimorbidity and mortality from COVID-19 in the Middle East and North Africa region, where such data are scarce. We conducted a cross-sectional study using data of all cases with COVID-19 reported to the Ministry of Public Health of Qatar from March to September 2020. Data on pre-existing comorbidities were collected using a questionnaire and multimorbidity was defined as having at least two comorbidities. Proportions of deaths were compared by comorbidity and multimorbidity status and multivariable logistic regression analyses were carried out. A total of 92,426 participants with a mean age of 37.0 years (SD 11.0) were included. Mortality due to COVID-19 was associated with gastrointestinal diseases (aOR 3.1, 95% CI 1.16–8.30), respiratory diseases (aOR 2.9, 95% CI 1.57–5.26), neurological diseases (aOR 2.6, 95% CI 1.19–5.54), diabetes (aOR 1.8, 95% CI 1.24–2.61), and CVD (aOR 1.5, 95% CI 1.03–2.22). COVID-19 mortality was strongly associated with increasing multimorbidity; one comorbidity (aOR 2.0, 95% CI 1.28–3.12), two comorbidities (aOR 2.8, 95% CI 1.79–4.38), three comorbidities (aOR 6.0, 95% 3.34–10.86) and four or more comorbidities (aOR 4.15, 95% 1.3–12.88). This study demonstrates a strong association between COVID-19 mortality and multimorbidity in Qatar.
- 20 February 2023
- Published by MDPI AG in Microbiology Research
- Vol. 14 (1) , 289-296
Open AccessAssociation between Multimorbidity and COVID-19 Mortality in Qatar: A Cross-Sectional Study
This study assessed the association between multimorbidity and mortality from COVID-19 in the Middle East and North Africa region, where such data are scarce. We conducted a cross-sectional study using data of all cases with COVID-19 reported to the Ministry of Public Health of Qatar from March to September 2020. Data on pre-existing comorbidities were collected using a questionnaire and multimorbidity was defined as having at least two comorbidities. Proportions of deaths were compared by comorbidity and multimorbidity status and multivariable logistic regression analyses were carried out. A total of 92,426 participants with a mean age of 37.0 years (SD 11.0) were included. Mortality due to COVID-19 was associated with gastrointestinal diseases (aOR 3.1, 95% CI 1.16–8.30), respiratory diseases (aOR 2.9, 95% CI 1.57–5.26), neurological diseases (aOR 2.6, 95% CI 1.19–5.54), diabetes (aOR 1.8, 95% CI 1.24–2.61), and CVD (aOR 1.5, 95% CI 1.03–2.22). COVID-19 mortality was strongly associated with increasing multimorbidity; one comorbidity (aOR 2.0, 95% CI 1.28–3.12), two comorbidities (aOR 2.8, 95% CI 1.79–4.38), three comorbidities (aOR 6.0, 95% 3.34–10.86) and four or more comorbidities (aOR 4.15, 95% 1.3–12.88). This study demonstrates a strong association between COVID-19 mortality and multimorbidity in Qatar.